As of 3:59pm ET
| +0.14 / +2.71%|
The 4 analysts offering 12-month price forecasts for Aratana Therapeutics Inc have a median target of 8.50, with a high estimate of 15.00 and a low estimate of 8.00. The median estimate represents a +60.08% increase from the last price of 5.31.
The current consensus among 5 polled investment analysts is to Buy stock in Aratana Therapeutics Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.